Trump Signs Executive Order to Boost U.S. Drug Manufacturing

Intermediate Level | May 12, 2025

✨ Read the article aloud on your own or repeat each paragraph after your tutor.

Executive Order Aims to Strengthen Domestic Pharmaceutical Production

On May 5, 2025, President Donald Trump signed an executive order designed to encourage pharmaceutical manufacturing within the United States. The order directs the Food and Drug Administration (FDA) to streamline the approval process for domestic pharmaceutical plants and collaborate with manufacturers before facilities become operational. Additionally, it enhances oversight of foreign active-ingredient producers and calls for potential public disclosure of non-compliant facilities.

National Security Concerns Drive Policy Shift

The administration cites national security concerns over the U.S.’s reliance on foreign-produced medicines, with over \$200 billion in prescription drugs imported annually. President Trump emphasized the need to reduce this dependence, stating, “We will produce our medical supplies, pharmaceuticals, and treatments right here in the United States.”

Pharmaceutical Industry Responds with Increased U.S. Investments

In response to the executive order and potential tariffs on pharmaceutical imports, several major drugmakers have announced significant investments in U.S. manufacturing:

Bristol Myers Squibb plans to invest $40 billion over the next five years to expand research and manufacturing capabilities.
Gilead Sciences has announced an additional $11 billion investment to enhance domestic manufacturing and research, bringing its total planned U.S. investment to $32 billion through 2030.
Merck Animal Health is investing $895 million to expand its manufacturing facility in Kansas, expected to create over 200 full-time jobs.

Industry Skepticism and Challenges Ahead

Despite these investments, some industry leaders express skepticism about the executive order’s effectiveness in accelerating domestic drug production. Novo Nordisk’s CFO, Karsten Munk Knudsen, noted that establishing compliant pharmaceutical facilities in the U.S. typically takes years, and he doubts the executive action will significantly reduce industry timelines.

Vocabulary

Executive order (noun): an official directive from the President to federal agencies.
- Example: The President signed an executive order to boost domestic manufacturing.
Streamline (verb): to make a process more efficient or straightforward.
- Example: The company streamlined its operations to reduce costs.
Oversight (noun): the action of overseeing something.
- Example: The committee has oversight of the project.
Tariff (noun): a tax imposed on imported goods.
- Example: The government imposed tariffs on steel imports.
Investment (noun): the action or process of investing money for profit.
- Example: The company made a significant investment in new technology.
Manufacturing (noun): the process of producing goods from raw materials.
- Example: The factory specializes in the manufacturing of pharmaceutical products.
Compliance (noun): following rules or standards.
- Example: The plant must maintain strict compliance with FDA regulations.
Facility (noun): a place designed for a specific purpose, such as production or research.
- Example: The new facility will help expand domestic drug production.
Directive (noun): an official instruction or order.
- Example: The company followed the directive issued by the health department.
Supply chain (noun): the sequence of processes involved in the production and distribution of a product.
- Example: Disruptions in the supply chain led to delays in medication delivery.

Discussion Questions (About the Article)

What is the purpose of the executive order signed by President Trump?
Why is there a push to increase domestic pharmaceutical manufacturing?
How are pharmaceutical companies responding to the executive order?
What challenges might companies face in shifting production to the U.S.?
Do you think the executive order will effectively reduce reliance on foreign-produced medicines? Why or why not?

Discussion Questions (About the Topic)

How can a country balance national security concerns with global trade relationships?
What are the potential benefits and drawbacks of imposing tariffs on pharmaceutical imports?
In what ways can government policies influence the decisions of large corporations?
How might increased domestic manufacturing impact drug prices for consumers?
What role does innovation play in the pharmaceutical industry’s ability to adapt to policy changes?

Related Idiom

“Bring something home”
Meaning: To make something more relevant or understandable to someone.
Example: The executive order brings home the importance of domestic drug manufacturing.

📢 Want more practical English lessons like this? Sign up for the All About English Mastery Newsletter at allaboutenglishmastery.com/newsletter!

Follow our YouTube Channel @All_About_English for more great insights and tips.

📰 Source

This article was inspired by Reuters, May 6, 2025.